Danish firm Orsted halts huge UK offshore wind farm project
Danish renewables firm Orsted said Wednesday it was shelving plans to build a massive wind farm off the UK coast due to rising costs, dealing a setback to Britain's clean energy goals.
The 2,400-megawatt Hornsea 4 project would have complemented two existing Orsted wind farms and a third under construction.
But Orsted said in a statement that the project "has seen several adverse developments", including rising supply chain costs, higher interest rates and an increased risk in building it on the planned timeline.
"We've decided to discontinue the development of the Hornsea 4 project in its current form," Orsted chief executive Rasmus Errboe said.
"The adverse macroeconomic developments, continued supply chain challenges, and increased execution, market and operational risks have eroded the value creation," he added.
The existing Hornsea 1 and 2 wind farms and the Hornsea 3 project will have a combined capacity exceeding five gigawatts.
Orsted said shelving the Hornsea 4 project would cost the company between 3.5 billion and 4.5 billion kroner ($533 million and $685 million).
"I'd like to emphasise that Orsted continues to firmly believe in the long-term fundamentals of and value perspectives for offshore wind in the UK," Errboe said.
"We'll keep the project rights for the Hornsea 4 project in our development portfolio, and we'll seek to develop the project later in a way that is more value-creating for us and our shareholders."
The British government said it would work with Orsted to revive the project.
"We recognise the effect that globally high inflation and supply chain constraints are having on industry across Europe," said a spokesperson for Britain's Department for Energy Security and Net Zero.
"We will work with Orsted to get Hornsea 4 back on track," the spokesperson said.
Orsted was already dealt a $4 billion blow in 2023 when it cancelled wind farm projects in the United States, a crucial market for the group.
Now the entire sector faces a major challenge in the United States after President Donald Trump froze federal permitting and loans for all offshore and onshore wind projects.
Orsted also reported first-quarter results on Wednesday showing sales rose eight percent to 20.7 billion kroner, lower than the 21.7 billion kroner forecast by analysts surveyed by financial data firm FactSet.
Its net profit, however, nearly doubled to 4.8 billion kroner.
cbw/lth/yad
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
11 hours ago
- CNBC
These stocks reporting earnings next week have a history of topping analysts' estimates
Just a handful of companies reporting earnings next week have a track record of beating Wall Street's expectations. Palo Alto Networks and Intuit are on that list. Second-quarter earnings have assuaged investors' fears about slowing economic growth. More than 80% of S & P 500 companies that have reported so far have posted a positive earnings surprise for the second quarter, which is above the five-year average, according to FactSet data. More often than not, stocks can get a boost from strong earnings results. With this in mind, CNBC Pro screened data from Bespoke Investment Group for companies due to report next week that have a history of beating earnings expectations and then rising on the back of those results. The stocks below have beaten earnings expectations, on average, 75% of the time and posted a move of at least 1% on the reporting day. Take a look: One company that topped the list was Palo Alto Networks, which has a 94% average earnings beat rate and boasts an average postearnings move of 1.1%. Shares of the cybersecurity company are down more than 3% this year, but jumped more than 5% this week. Palo Alto Networks has seen a series of upgrades and price target increases in recent days as Wall Street assesses the company's announcement to acquire Israeli identity security platform CyberArk in a deal valued at roughly $25 billion. Deutsche Bank analyst Brad Zelnick on Tuesday upgraded Palo Alto Networks to buy from hold and lifted his price target by $20 to $220, which implies about 25% potential upside. "Despite recent share underperformance and some investor questions following the announced CYBR deal, the core business appears to be humming along nicely," Zelnick said. PANW 1Y mountain Palo Alto Networks stock over the past year. Intuit also has a history of exceeding analysts' earnings expectations, with an average beat rate of 87%. Shares of the financial planning company are up more than 14% this year. Intuit is one of the leading software adopters of artificial intelligence , with its chief financial officer having said during the company's earnings call in May that internally deployed AI tools have increased the productivity of its developers. Bank of America is one Wall Street firm that is bullish on Intuit's position in the AI race. Analyst Brad Sills said in a June 12 note that he views "Intuit as a key AI beneficiary in software, with a multi-year adoption and monetization cycle in the [small- and medium-sized business] and consumer segments" as the company capitalizes on AI adoption across products including Turbo Tax, Credit Karma, QuickBooks and Mailchimp. Other stocks that made the cut are Analog Devices and Keysight Technologies , which have generally beaten earnings 90% and 77% of the time, respectively.
Yahoo
12 hours ago
- Yahoo
EXCLUSIVE: Net-a-porter Alums Raise $1 Million for U.K.-based Egg and Sperm Health Supplement Company Ova
Egg and sperm health brand Ova has secured a $1 million pre-seed from Era VC, Ventures Together and Syndicate Room and angel investors including Gemma Bellman, former director at Glossier and the British Beauty Council; Lisa Gordon, chairperson at Cavendish Capital; Stratos Chatzigiannis, chief executive officer of Ila Apothecary, and more. Ova, which is based in the U.K., currently offers four products, including Ova Her, a fertility and pregnancy support supplement that is the brand's bestseller; Ova Him, a sperm support supplement that is the brand's bestseller in-store; Ova Plus, a hormone support supplement, and Ova Omega, an omega-3 supplement formulated for reproductive health. More from WWD Report: Shoppers Spending $47 More Per Month Under Trump's Tariff Regime Les Tien Debuts First Los Angeles Store British Retailer Boden Set to Open First U.S. Store in Georgia 'Ova is tapping into a deeply underserved space in a truly differentiated manner,' said Claire Cherry, partner at Era VC. 'We know fertility is no longer solely a women's issue — it's a team effort, and Ova is leading the charge with a standout brand and real science. We're proud to back such an exceptional team.' Ova, which launched seven months ago, was founded by Net-a-porter alums Danielle Fox-Thomas and Kat Lestage, who were both experiencing their own fertility challenges which ultimately led to them building Ova while they each were pregnant. 'It was quite the challenge, but we like a challenge,' said Fox-Thomas, who was previously a health and beauty editor. 'I went through a round of IVF. Kat went through her own challenges, but was happily pregnant. Then I got pregnant quite quickly after my round, so we were essentially both pregnant as we were raising, giving birth and launching the brand.' She added: 'It just so happened [that] we created our own Ova babies, just to put the icing on the cake.' According to Lestage, going through this experience while raising capital allowed them to find investors who were the perfect fit. 'I do think some people probably might be and maybe were a bit intimidated by the fact that we're two women who are starting a business while at the same time growing and starting families,' said the former beauty and wellness buyer. 'For us, building a brand that is made for people who are starting and growing their families, it makes the most sense for the people who are leading that business to be going through that themselves. We wanted investors who believed in that vision.' Upon starting the brand, retailers were automatically interested given the opportunity within the category. 'Especially in the U.K., there was a lot of white space for there to be a brand that was speaking to a more modern consumer. Something as simple as our branding, is very straightforward. It is like, 'This is fertility [and] pregnancy. This is advanced sperm support. This is for your advanced hormonal support,'' Lestage said. 'We're not trying to be quiet. We're not putting babies on boxes.…It's something new and it's fresh, and we're talking to that modern consumer. That's what buyers bought into quickly.' Boots, in particular, brought on Ova before the brand had even turned on its direct-to-consumer shop. Now the brand is available in more than 900 doors with Boots, the largest pharmacy chain in the U.K., and Sainsbury's, one of the largest grocery retailers in the U.K., and will be expanding in Ireland. 'What this raise has done is allowed us to support our retailers in not going out of stock. We've expanded with Boots, moved into Republic of Ireland. We're going into more stores in Ireland in October,' Lestage said. 'Our growth with Boots has been crazy, and so this raise has really allowed us to continue to fuel that growth.…In addition to that, which we're very excited about, is we finally have been able to turn on paid ads for our DTC.' Fox-Thomas added that they are also beginning to discuss future product development. 'We're looking at PMS. We're looking at how we can best support those coming off birth control, how we can best support those with symptoms of PCOS and more regularity of cycle, and then looking at hunkering down on those who are going through assisted reproductive technologies,' Fox-Thomas said. 'We want to be known for reproductive health [and] fertility. We know this is not going away anytime soon. One in four of us will struggle or face challenges, but we want to lean to more positive, actionable products that really can help support.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 hours ago
- Yahoo
Carlsberg gloomy on consumer environment but lifts low end of guidance
Carlsberg does not expect consumer environment to improve in the back half but has nonetheless lifted the lower end of its full-year sales growth guidance. In a statement alongside the Danish brewing giant's first half and second-quarter results yesterday (14 August), CEO Jacob Aarup-Andersen said: "We don't expect the consumer environment to improve over the remainder of the year. "Nevertheless, we're continuing our long-term investments in key brands and capabilities, including in areas such as digital, marketing and value management, to create an even stronger Carlsberg." For the half year period ended 30 June 2025, the 1664 Blanc maker saw reported revenue grow 18.2% to Dkr45.9bn ($7.1bn), which the company attributed to the acquisition of Britvic. On an organic basis, revenue declined 0.3%, driven by the company's loss of its UK production, distribution and marketing license for San Miguel to Budweiser in July. Operating profit was up 15.1% on a reported basis and grew 2.3% in organic terms, to Dkr7.2bn. Total volumes decreased 16% on a reported basis but declined 1.7% organically to 76.3 million hectolitres. In its second quarter, the business saw total organic revenue rise 0.6% to Dkr25.73bn, excluding the impact from San Miguel. Total organic volumes of both the beer and other beverages segments grew 0.2% in the three months, again excluding San Miguel, to 42.9 million hectolitres. In spite of the negative outlook for the remainder of the year, Carlsberg confirmed its intention to narrow its earning guidance for 2025. The business now expects to see 3% to 5% growth in organic operating profit, compared to a prior 1% to 5% forecast. 'Being able to narrow our earnings guidance towards the upper end of the range in a difficult trading environment reflects our relentless focus on commercial execution, as well as continued strong performance management and cost discipline", Aarup-Andersen added. In terms of markets, in its first-half Carlsberg saw volumes in Western Europe dip 1.7% organically but rise 44.8% on a reported basis to 30.8 million hectolitres. Revenue in the region was up 34.9% on a reported basis and down 0.8% organically at Dkr25.45bn. The company's Asia market saw total volumes decline 2.8% in the period on an organic basis and reported basis to 25 million hectolitres. Revenue in the region slipped 1.9% organically and 4.1% on a reported basis to Dkr11.2bn. In Asia in particular, the company saw an impact on beer volumes, which dropped 1.7% organically to 22 million hectolitres, driven by soft volumes in Cambodia and Laos. The group's 'other beverages' segment saw a 10.4% organic decline to 3 million hectolitres due to an impact on energy drinks in Cambodia. Carlsberg also said it faced "weak consumer sentiment" in China for its mainstream beer portfolio as well as "intensified competitive activities" in Vietnam, which had a negative effect on volumes in the country. Speaking to reporters yesterday on how volumes might look in the second half of the company's fiscal year, Aarup-Andersen said the business didn't anticipate seeing "any significant change versus the first half", but noted that it did "assume a slightly better volume development in the second half". He added: "If you look across the three regions, we've had a good start to Q3 in Western Europe, in Asia... but even around China, of course, it's a major factor, and we don't see a step change in China, but we do expect that Vietnam will be less bad in the second half than in the first half, and we also expect Laos to improve." "Carlsberg gloomy on consumer environment but lifts low end of guidance" was originally created and published by Just Drinks, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
